1. Home
  2. OPRA vs TNDM Comparison

OPRA vs TNDM Comparison

Compare OPRA & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opera Limited

OPRA

Opera Limited

HOLD

Current Price

$18.81

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

HOLD

Current Price

$17.08

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRA
TNDM
Founded
1996
2006
Country
Norway
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
OPRA
TNDM
Price
$18.81
$17.08
Analyst Decision
Strong Buy
Buy
Analyst Count
1
19
Target Price
$21.50
$28.00
AVG Volume (30 Days)
378.3K
2.8M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
4.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,014,736,000.00
Revenue This Year
$21.29
$8.11
Revenue Next Year
$15.34
$11.85
P/E Ratio
$13.62
N/A
Revenue Growth
N/A
7.93
52 Week Low
$11.71
$10.00
52 Week High
$21.06
$29.65

Technical Indicators

Market Signals
Indicator
OPRA
TNDM
Relative Strength Index (RSI) 64.63 52.21
Support Level $13.08 $11.86
Resistance Level $19.24 $21.68
Average True Range (ATR) 0.58 1.11
MACD -0.03 0.39
Stochastic Oscillator 99.05 80.07

Price Performance

Historical Comparison
OPRA
TNDM

About OPRA Opera Limited

Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: